Join the NC TraCS Comparative Effectiveness Research team and guest expert Timothy Sheahan, PhD, to discuss the phase 2 trial results of molnupiravir, the new potential treatment for COVID-19.
Journal article for this discussion: Molnupiravir, an Oral Antiviral Treatment for COVID-19 - https://www.medrxiv.org/content/10.1101/2021.06.17.21258639v1
Discussion Leaders
Michele Jonsson-Funk, PhD, Associate Professor
Epidemiology, Gillings School of Global Public Health
Timothy Sheahan, PhD Assistant Professor
Epidemiology, Gillings School of Public Health
Sara Dejene, PhD Candidate
Epidemiology, Gillings School of Global Public Health